Examples of such genes are: RNASET2, a known tumor antagonist in melanoma (Monti et al., 2008); and FCRL1, encoding a glycoprotein linked to the disease’s progression (Koh et al., 2012). This evidence concerns the gene FCRL1 and melanoma.